SurgePays (SURG) Fundamental Analysis: Revenue, Earnings & Valuation

0.71 / 10

Underperform

Fundamental assessment rates SURG as Underperform. Core metrics such as Asset‑MV, Profit‑MV and Cash‑UP are negative, while PB‑ROE shows modest upside. Overall the company’s financial health is weak, suggesting prudent positioning.

Analysis Checks(1/10)

Revenue-MV

Value0.39

Score0/3

Weight39.86%

1M Return-11.48%

Profit-MV

Value0.40

Score1/3

Weight6.52%

1M Return-1.47%

Net income-Revenue

Value-0.15

Score1/3

Weight-3.37%

1M Return0.82%

PB-ROE

Value2.90

Score2/3

Weight-19.16%

1M Return3.50%

Basic earnings per share (YoY growth rate %)

Value18.98

Score0/3

Weight6.54%

1M Return-1.48%

Total profit (YoY growth rate %)

Value3.37

Score0/3

Weight11.65%

1M Return-2.88%

Cash-UP

Value-0.01

Score0/3

Weight28.46%

1M Return-7.26%

Diluted earnings per share (YoY growth rate %)

Value18.98

Score0/3

Weight10.46%

1M Return-2.39%

Asset-MV

Value-0.49

Score1/3

Weight11.04%

1M Return-2.78%

Net profit attributable to parent company shareholders (YoY growth rate %)

Value14.31

Score0/3

Weight8.00%

1M Return-1.84%

Is SURG fundamentally strong?

SURG scores 0.71/10 on fundamentals and holds a Premium valuation at present. Backed by its -502.58% ROE, -83.76% net margin, -0.35 P/E ratio, -2.63 P/B ratio, and -83.62% earnings growth, these metrics solidify its Underperform investment rating.